![Matthew T. Seibt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Matthew T.
Seibt worked as the Chief Commercial Officer at Acer Therapeutics, Inc. from 2019 to 2023.
Prior to that, he held a former job at the same company from 2018.
He received his undergraduate degree from The University of Texas at Austin.
Anciens postes connus de Matthew T. Seibt
| Sociétés | Poste | Fin |
|---|---|---|
| ACER THERAPEUTICS INC. | Corporate Officer/Principal | 01/03/2023 |
Formation de Matthew T. Seibt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
